Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Ex vivo antigen and adjuvant pulsed peripheral blood mononuclear cells as a screening platform for candidate novel vaccines and candidate antigens

Ex vivo antigen and adjuvant pulsed peripheral blood mononuclear cells as a screening platform for candidate novel vaccines and candidate antigens

US Patent 11422127 · Granted Aug 23, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for diagnosing an inflammatory bowel disease based on soluble tumor necr2025
Assay apparatuses, methods and reagents2025
Process for the preparation of recombinant lectin protein2025
Reagent storage in an assay device2025
Assay cartridge valve system2024
Assay cartridges and methods of using the same2024
Recombinant lectin variants2024
Biodosimetry panels and methods2024
Methods for conducting multiplexed assays2024
Redirecting to a trusted device for secured data transmission2024
Assay cartridges and methods of using the same2024
Assay apparatuses, methods and reagents2024